BlackRock Health Sciences Opportunities Portfolio Service Shares (SHISX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

66.91

-0.54 (-0.80%)

Aug 26, 2026, 4:00 PM EST

12.59% (1Y)

Fund Assets	6.09B
Expense Ratio	1.14%
Min. Investment	$5,000
Turnover	43.00%
Dividend (ttm)	0.16
Dividend Yield	0.24%
Dividend Growth	32.38%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	67.45
YTD Return	13.59%
1-Year Return	30.45%
5-Year Return	34.37%
52-Week Low	59.04
52-Week High	70.24
Beta (5Y)	0.69
Holdings	159
Inception Date	Jan 28, 2005

About SHISX

BlackRock Health Sciences Opportunities Fund Service Shares is an actively managed mutual fund that primarily targets capital appreciation by investing at least 80% of its assets in equity securities of companies operating within the health sciences and related industries. The fund’s portfolio is composed mainly of large-cap healthcare companies, with significant holdings in sectors such as pharmaceuticals, biotechnology, medical devices, and healthcare services. Top positions include notable names like Eli Lilly and Co, Boston Scientific, AbbVie, Abbott Laboratories, and UnitedHealth Group, reflecting a focus on both stability and innovation within the healthcare sector. The fund may also allocate a portion of its assets to non-U.S. companies, broadening its reach within global health sciences. With total assets of approximately $6.5 billion, the fund is positioned as a significant player in the healthcare investment arena and seeks to capture the growth and resilience characteristic of the industry's major participants. It charges an expense ratio of 1.14% and is structured as a no-load fund, targeting investors seeking dedicated exposure to healthcare equities without the constraints of index tracking.

Fund Family BlackRock

Category Health

Performance Rating Above Average

Risk Rating Low

Stock Exchange NASDAQ

Ticker Symbol SHISX

Share Class Service

Index Russell 3000 Healthcare TR

Performance

SHISX had a total return of 30.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.99%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSSX	Institutional	0.84%
SHSAX	Investor A	1.09%
SHSCX	Investor C	1.86%

Top 10 Holdings

53.00% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.68%
Johnson & Johnson	JNJ	7.87%
UnitedHealth Group Incorporated	UNH	6.34%
Merck & Co., Inc.	MRK	5.26%
AbbVie Inc.	ABBV	5.11%
Gilead Sciences, Inc.	GILD	3.74%
Amgen Inc.	AMGN	3.44%
Thermo Fisher Scientific Inc.	TMO	3.18%
Vertex Pharmaceuticals Incorporated	VRTX	2.89%
Edwards Lifesciences Corporation	EW	2.49%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$3.01803	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.21472	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$1.13184	Dec 8, 2023

Full Dividend History